169277 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer
#302Monoclonal antibodies and diagnostic uses thereof
#303Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
#304PROXIMITY-MEDIATED ASSAYS FOR DETECTING ONCOGENIC FUSION PROTEINS
#305RISK VARIANTS FOR CANCER
#306Antibodies For Oncogenic Strains Of HPV And Methods Of Their Use
#307RAF gene fusions
#308ANTIBODIES SPECIFIC TO E6 PROTEINS OF HPV AND USE THEREOF
#309ERG monoclonal antibodies
#310Tumor cell-derived microvesicles
#311METHODS OF DIAGNOSING CERVICAL CANCER
#312CONNEXIN ENHANCES CHEMOTHERAPY-INCLUDED APOPTOSIS IN HUMAN CANCER CELLS INHIBITING TUMOR CELL PROLIFERATION
#313Method for Determining the Cbl-b Expression
#314MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#315CHEMICAL INHIBITOR OF P53-SNAIL BINDING AND PHARMACEUTICAL COMPOSITION FOR TREATING CANCER DISEASE CONTAINING SAME AS ITS ACTIVE INGREDIENT
#316Diagnosis and treatment of breast cancer
#317MSH2 AND ADJUVANT CISPLATIN-BASED CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCER
#318SMALL SPECIMEN STAINING AND DIAGNOSING OF CELLS
#319Phosphorylated RaIA
#320Methods for Cancer Diagnosis, Anti-Cancer Drug Screening, and Test of Drug Effectiveness on the Basis of Phoshorylation of Ras at Thr-144 and Thr-148
#321COMPOSITIONS AND METHODS FOR DETECTING CANCER
#322Methods for Treating Cancers Comprising K-ras Mutations
#323UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER
#324UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER
#325Compositions against cancer antigen LIV-1 and uses thereof
#326Anti-c-Met antibody
#327BCR-ABL truncation mutations
#328INHIBITORS OF ONCOGENIC ISOFORMS AND USES THEREOF
#329ANTI-ErbB2 ANTIBODIES
#330MN/CA IX and EGFR Pathway Inhibition
#331Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma
#332Marks as modifiers of the p53 pathway and methods of use
#333Human Cancer Stem Cell Culture Compositions Comprising ErbB2 Variants and Methods of Use
#334HADHs as Modifiers of the p21 Pathway and Methods of Use
#335MN/CA IX and cancer prognosis
#336DISCOVERY AND VALIDATION OF CANCER BIOMARKERS USING A PROTEIN ANALYSIS METHODOLOGY TO ANALYZE SPECIMENS
#337TUMOR CELL-DERIVED MICROVESICLES
#338MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#339Immunological compositions as cancer biomarkers and/or therapeutics
#340Antibodies for oncogenic strains of HPV and methods of their use
#341INHIBITION OF CELL PROLIFERATION
#342Quantitative Assays for Ras p21 in Body Fluids
#343SCDs as modifiers of the p53 pathway and methods of use
#344PEPTIDES DERIVED FROM RAS-P21 AND USES THEREFOR
#345Oncolytic viruses as phenotyping agents for neoplasms
#346Anti-phospho-Akt antibodies
#347Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571
#348ACTIVATED HER3 AS A MARKER FOR PREDICTING THERAPEUTIC EFFICACY
#349Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same
#350BARB4 TARGET, ANTIBODY DESIGNATED BARB4, BARB4 RELATED ANTIBODIES, AND METHODS OF MAKING AND USING SAME
#351METHODS FOR DIAGNOSING AND TREATING CANCERS VIA MANIPULATIONS OF A...PATHWAY
#352MN/CA IX and cancer prognosis
#353Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
#354SEMA4D in cancer diagnosis, detection and treatment
#355Modulation of line-1 reverse transcriptase
#356Antibodies for oncogenic strains of HPV and methods of their use
#357Modulation of line-1 reverse transcriptase
#358SELECTING PATIENTS FOR THERAPY WITH A HER INHIBITOR
#359SHC protein-related methods and compositions
#360Methods Kits and Compositions for the Developement and Use of Monoclonal Antibodies Specific to Anbtigens of Low Immunogenicity
#361C-erbB-2 external domain: GP75
#362CELL REGULATORY GENES, ENCODED PRODUCTS, AND USES RELATED THERETO
#363Methods of determining cellular chemosensitivity
#364p53 wild-type as biomarker for the treatment with mTOR inhibitors in combination with a cytotoxic agent
#365Compositions Against Cancer Antigen LIV-1 and Uses Thereof
#366MARKs as Modifiers of the p53 Pathway and Methods of Use
#367CONNEXIN ENHANCES CHEMOTHERAPY-INDUCED APOPTOSIS IN HUMAN CANCER CELLS INHIBITING TUMOR CELL PROLIFERATION
#368Methods of diagnosing cervical cancer
#369MN/CA IX and EGFR pathway inhibition
#370Anti-ErbB2 antibodies
#371SCDs As Modifiers of the p53 Pathway and Methods of Use
#372Human cancer stem cell culture compositions comprising Erbb2 variants and methods of use thereof
#373UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER
#374Oncolytic viruses as phenotyping agents for neoplasms
#375Use of nelfinavir as a radiation sensitizer
#376Foldable polymers as probes
#377Screening Assay and Treatment
#378Methods for Detecting DNA Damage and Screening for Cancer Therapeutics
#379Multiplex in situ immunohistochemical analysis
#380Systems of diagnosing cervical cancer
#381Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseases
#382Novel compositions and methods in cancer
#383MN/CA IX and cancer prognosis
#384Crystal structure of human Pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
#385Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
#386Bcl2L12 polypeptide activators and inhibitors
#387Genes and polypeptides relating to myeloid leukemia
#388LIMKs as modifiers of p53 pathway and methods of use
#389Novel compositions and methods in cancer
#390Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases
#391Selecting patients for therapy with a her inhibitor
#392Lymphatic and blood endothelial cell genes
#393Cancer specific gene MH15
#394Differential diagnosis of cancer and other conditions based on expression of p63
#395Three-dimensional structure of c-Abl
#396Biomarkers for diagnosis, prognosis, monitoring, and treatment decisions for drug resistance and sensitivity
#397C-erbB-2 external domain: gp75
#398Cell regulatory genes, encoded products, and uses related thereto
#399Methods of diagnosing cervical cancer
#400Use of Pin1 inhibitors for treatment of cancer
#401Screening method
#402HADHs as modifiers of the p21 pathway and methods of use
#403HADHs as modifiers of the p21 pathway and methods of use
#404Chds as modifiers of the p53 pathway and methods of use
#405Antibodies for oncogenic strains of HPV and methods of their use
#406Assay and treatment
#407Modulation of line-1 reverse transcriptase
#408Dgks as modifiers of the p53 pathwha and methods of use
#409Compound and uses thereof
#410Methods for inhibiting deacetylase activity
#411Diagnosing and treating cancer cells using mutant viruses
#412Methods of treating a neuroendocrine tumor